about
Quantification of crypt and stem cell evolution in the normal and neoplastic human colonTPPII promotes genetic instability by allowing the escape from apoptosis of cells with activated mitotic checkpoints.Evolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett's oesophagusLineage tracing reveals multipotent stem cells maintain human adenomas and the pattern of clonal expansion in tumor evolution.Dissecting the non-canonical functions of telomerase.Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread.Analysis of clonal expansions through the normal and premalignant human breast epithelium reveals the presence of luminal stem cells.Role of SMAD proteins in colitis-associated cancer: from known to the unknown.Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy.Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments.The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas.Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy.Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas.Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans.Crypt fusion as a homeostatic mechanism in the human colonQuantification of Crypt and Stem Cell Evolution in the Normal and Neoplastic Human Colon
P50
Q28246034-9570309C-B6D1-44C7-A8CF-199B4147A2CBQ34536149-A9F4B38F-C9EF-4EB9-88D1-2EE99098BF79Q36968814-F03A70D8-5CE2-4101-B59E-7CF7B0A93271Q36991078-B6F60BCB-9CBB-4824-AB33-668A24EED9E5Q37384122-0340EAA2-F03B-4213-817A-B3BBEB1853E7Q38920450-BF491403-A893-48B3-8868-C7E9BC00BC84Q47756636-FE08DC70-6292-4ABF-BB5F-481422F7C0C0Q47860432-9888659E-4C0E-4BF2-8796-792286A7FFD4Q49787688-4258812C-1B65-4198-94FA-DE24CB7191B0Q52645861-0D322F00-57C0-463D-BAB5-9C97AB7DD352Q52655036-60BCB8CA-1B44-44AB-983C-BEB4A7014635Q54123039-5504154D-8BB6-40F6-8DC3-6B3F8EFD744BQ55002996-7F5E6DE0-A11C-43F8-AD59-D017C3BE107AQ55004551-F97F8851-0A11-4868-87A3-EC347B325B63Q55040335-A9679B65-8079-43FC-B0A8-CD446EF3BD54Q55130823-A68DE22A-88C4-4EC6-89D0-98EEE8580EC9Q63487465-154537F9-8D9D-4222-BDE6-8DF3977D6C79Q64281076-1153CAB2-68DA-4578-9015-C2400A1380F9
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
B Cereser
@en
B Cereser
@nl
type
label
B Cereser
@en
B Cereser
@nl
prefLabel
B Cereser
@en
B Cereser
@nl
P31
P496
0000-0003-1243-1767